Investigation on the survival implications of PD-L1 expression status in ALK- rearranged advanced non-small cell lung cancer treated with first-line crizotinib
- Resource Type
- Article
- Source
- In
Lung Cancer May 2022 167:58-64 - Subject
- Language
- ISSN
- 0169-5002